Physician profile
Andrew Hung
NPI 1972954980
$3,436.23
in general payments reported to CMS, 2019-2025
11 companies · $429 in 2025
The $429 reported for 2025 was more than what 77% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $306 · 2022: $1,826 · 2023: $271 · 2024: $604 · 2025: $429.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,305.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,304.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,369.83 | 2021-2022 | |
| Getinge USA Sales, LLC | $978.52 | 2022-2025 | Vasoview Hemopro 2, Vasoview Hemopro 2, Heartstring III Proximal Seal |
| Atricure, INC. | $277.30 | 2021-2025 | Atriclip Laa Exclusion System, Isolator Surgical Ablation System, Synergy Ablation System |
| Abiomed | $260.76 | 2022-2025 | Impella |
| Becton, Dickinson and Company | $146.45 | 2021 | |
| Ethicon US, LLC | $115.44 | 2024-2025 | Surgiflo Hemostatic Matrix, Vistaseal, Stratafix |
| Abbott Laboratories | $95.30 | 2024 | Epic, Dragonfly Opstar |
| Smith+Nephew, INC. | $77.30 | 2023 | Renasys Go V2 Home, Pico |
| Gilead Sciences, INC. | $58.93 | 2024 | |
| Solventum Corporation | $34.50 | 2025 | Prevena Restor Bellaform, Prevena |
| Stryker Corporation | $21.90 | 2023 | Spy-Phi System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Hung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.